Yüklüyor......
Experimental Therapy of Advanced Breast Cancer: Targeting NFAT1–MDM2–p53 Pathway
Advanced breast cancer, especially advanced triple-negative breast cancer, is typically more aggressive and more difficult to treat than other breast cancer phenotypes. There is currently no curable option for breast cancer patients with advanced diseases, highlighting the urgent need for novel trea...
Kaydedildi:
| Yayımlandı: | Prog Mol Biol Transl Sci |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6663080/ https://ncbi.nlm.nih.gov/pubmed/29096894 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/bs.pmbts.2017.07.005 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|